2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of theCell and Gene Therapy Market?

The cell and gene therapy (CGT) market has grown due to continuous investments and consolidations within cell and gene therapies. Recognizing the potential of this market, 16 of the top 20 big biopharmaceutical firms by revenue have included CGT products in their range. For example, in 2023, according to the BioIndustry Association (BIA), which is UK-based and represents the life sciences and biotech sector, cell and gene therapy companies from the UK secured more than half of venture capital investments received by European companies. Typically, the UK accounts for about a third of all European venture capital investments in life sciences, which underscores the strength of its cell and gene therapy industry. Continuous investments and mergers in CGT production capacity have resulted in increased production and further market growth. For example, in October 2024, Purespring Therapeutics, a UK-based biotechnology firm, received a funding of $105 million to support kidney disease gene therapies development, including a phase 1/2 trial of a new treatment for immunoglobulin A nephropathy (IgAN). Purespring uses adeno-associated viruses (AAVs) to deliver its gene therapies into the body.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3472&type=smp

#What is the Anticipated CAGR of theCell and Gene Therapy Market, and What Factors Will Drive It?

In recent years, the cell and gene therapy market has experienced significant growth. It is projected to increase from a size of $12.01 billion in 2024 to a staggering $15.48 billion in 2025 with a compound annual growth rate (CAGR) of 28.9%. The historic surge in growth is driven by increased financial investment in cell and gene therapies, advancements in research and development, progress in the discovery of cancer drugs, an upswing in public-private collaborations, a robust economic upturn in developing markets, heightened healthcare costs, and an increase in expenditure on pharmaceutical research and development.

Over the coming years, the cell and gene therapy market is predicted to experience swift expansion, with projections indicating that it will reach $29.15 billion by 2029. This growth corresponds to a compound annual growth rate (CAGR) of 17.1%. Factors contributing to this growth during the forecast period include growing cases of cancer and chronic illnesses, an increase in the aging population, heightened emphasis on cell and gene therapy, and healthcare expenditure increases. Key trends for the forecast period include placing emphasis on cutting-edge therapies such as chimeric antigen receptor (CAR) T-cell therapy, focusing on launching various research initiatives and securing funding, implementing strategic collaborations to incorporate advanced technology, focusing on the development of gene or genome editing tools especially CRISPR, merging with or acquiring rivals, upscaling the number of pipeline research to develop cell and gene therapies, and investment in expanding production facilities.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3472

Which Upcoming Market Trends and Innovations Are Set to Influence theCell and Gene Therapy Market’s Path Forward?

The cell and gene therapy (CGT) market is being revolutionized by Chimeric antigen receptor (CAR) T-cell therapy. This therapy is a fusion of cell and gene therapy where T cells are modified with genetically engineered receptors, called Chimeric antigen receptors (CARs), after being collected from a patient’s blood. The modified T cells, now featuring specialized receptors, are then reintroduced into the patient’s body. These receptors aid in identifying and attacking cancer cells’ surface antigens, leading to the elimination of tumor cells. To illustrate, Bristol-Myers Squibb Company, an American pharmaceutical firm, got approval from the US Food and Drug Administration (US FDA) for its CAR T cell therapy Breyanzi in June 2022. This therapy is particularly meant for adult patients with large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma. Breyanzi, a unique CAR T cell therapy, is fabricated from a patient’s T cells, which are collected, genetically altered into CAR T cells, and then infused back into the patient as a stand-alone treatment.

Who Are the Dominant Market Players Pushing the Boundaries of theCell and Gene Therapy Market?

Major companies operating in the cell and gene therapy market include Biogen Inc., Novartis AG, Gilead Sciences, Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., ArrowHead Pharmaceuticals Inc., Spark Therapeutics, Bluebird Bio Inc., RegenexBio, Mesoblast Limited, Biocon, Cipla, Stempeutics Research Pvt. Ltd., EdiGene Inc., Immunochina, Takara Bio, Daiichi Sankyo Company, Ultragenyx Pharmaceutical Inc, Mitsubishi Tanabe Pharma, Oxford Biomedica plc, Santen Pharmaceutical Co., Therapeutic Innovation Australia, Merck, GenScript, Cellular Biomedicine Group, GE Healthcare, inStem, Lonza, Nikon CeLL innovation Co. Ltd., Bristol-Myers Squibb, Amgen, Pfizer, Kite Pharma, Oxford BioTherapeutics, Freeline Therapeutics, PsiOxus Therapeutics, Herantis Pharma Plc, AstraZeneca

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

What Are the Core Segments of the Cell and Gene Therapy Market, and How Do They Contribute to Growth?

The cell and gene therapy market covered in this report is segmented –

1) By Product: Cell Therapy, Gene Therapy

2) By Application: Oncology, Neurological Disorders, Other Applications

3) By End User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users

Subsegments:

1) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, CAR-T Cell Therapy

2) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Genome Editing Technologies, Antisense Oligonucleotide Therapy

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=3472&type=smp

What Regions Are Dominating the Cell and Gene Therapy Market Growth?

North America was the largest region in the cell and gene therapy market in 2024. The regions covered in the cell and gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Cell and Gene Therapy Market 2025, By The Business Research Company:

nucleic acid based gene therapy market, global nucleic acid based gene therapy market, nucleic acid based gene therapy market trends, nucleic acid based gene therapy market forecast, nucleic acid based gene therapy market analysis, nucleic acid-based therapeutics market, nucleic acid based gene therapy global market report 2021, nucleotide therapy market, gene therapy industry report, nucleic acid based gene therapy market report 2020

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market

Alpha Mannosidosis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/alphas-mannosidosis-global-market-report

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2031

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: